Member Info for avctIPmatters

Point had an early FAP version from Tufts not Canseek .

Lilly links :

https://www.lillyoncologypipeline.com/molecule/Lu-177-FAP/

https://www.lilly.com/innovation/clinical-development-pipeline

gmcc

Good Morning

Appreciate perhaps not foremost in most folks minds . Coris still an asset anyway be interesting to see who buys Coris - Few examples of third parties advertising /mentionong Coris AMR products :

--------------

Sebastien Goenen COO Coris Bioconcept

Sebastien Goenen likes this

AMS 2000 Trading Impex SRLAMS 2000 Trading Impex SRL

726 followers726 followers

3d • 3 days ago • Visible to anyone on or off LinkedIn

Follow

Discover step by step how to use the ReSCape kit – a kit with selective enrichment culture medium to accelerate the growth (3-4 hours) of gram-negative bacteria (C-PGNB), directly from fecal samples, for the detection of carbapenemelas, by watching the accompanying presentation video.

🔗 See the range CORIS BIOCONCEPT on www.corisbio.com 🌐 and contact us for a price offer. ↔️ ↔️ 🌐hashtag#distribuitorautorizat www.ams.ro

hashtag#CorisBioConcept hashtag#TesteRapide hashtag#Diagnostic hashtag#microbiologie

*post addressed to medical professionals

----------------------------------------

Sebastien’s profile photo

Sebastien Goenen likes this

View Carlos Espinoza Vásquez’s graphic link

Carlos Espinoza VásquezCarlos Espinoza Vásquez

• 3rd+3rd+

Clinical MicrobiologistClinical Microbiologist

1mo • Edited • 1 month ago • Edited • Visible to anyone on or off LinkedIn

Follow

Round 2!

This time it’s Citrobacter freundii who is under the spotlight. This guy was identified by MALDI Biotyper, using the MBT Sepsityper kit directly in positive blood culture samples. Along the way, considering that this is a critical ill patient, carbapenemase identification testing by lateral flow assay was performed directly from positive blood cultures (RUO) showing the presence of NDM carbapenemase🫣.

CORIS BIOCONCEPT"

---------------------------

Carlos Espinoza VásquezCarlos Espinoza Vásquez

• 3rd+3rd+

Clinical MicrobiologistClinical Microbiologist

1mo • Edited • 1 month ago • Edited • Visible to anyone on or off LinkedIn

Follow

Round 3🙌🏻

Positive blood culture ⤴️ Gram staining and ➡️ MBT Sepsityper Kit + lateral flow assay for carbapenemase identification (O.K.N.V.I. RESIST-5) 🟰 VIM-producing P. aeruginosa 👤🫆🫵🏻

CORIS BIOCONCEPT"

https://www.linkedin.com/in/sebastiengoenen/recent-activity/reactions/

Gmcc

Coris https://www.corisbio.com/products/

Nice to see David Wilson Avacta Chief Commercial Director still doing his bit to promote Coris : Hopefully Coris s find a good home .

https://www.linkedin.com/in/davidswilson/recent-activity/reactions/

-------------------

David Wilson likes this

View Eva Rennen’s graphic link

• 3rd+3rd+

Co-Founder & COO at Nostics - AI for ultrafast diagnosticsCo-Founder & COO at Nostics - AI for ultrafast diagnostics

5h • Edited • 5 hours ago • Edited • Visible to anyone on or off LinkedIn

Follow

There is more to diagnostics than you think.

Two major developments these past weeks show diagnostics is getting the recognition it deserves in antimicrobial resistance (AMR).

AMR is a global health crisis. It's projected to cause 10 million deaths per year and cost more than $150 billion by 2050. Diagnostics are key.

But here's the problem: Diagnostics is often seen as just this transactional thing. You get a test - and it either helps or it doesn't.

In reality, if you do more/better/faster diagnostics, there is a tremendous amount of 'hidden' value.

👏 First: The new "STRIDES Framework", made by the Office of Health Economics helps understand that ‘hidden’ value, change the perception and show the importance of diagnostics:

S = Spectrum - Enables narrow-spectrum, targeted antibiotics

T = Transmission - earlier detection & control reduces spread of infections

R = Research - accelerates antimicrobial development

I = Insurance - helps preserves last-line antibiotics

D = Diversity - reduces resistance pressure with targeted antimicrobials

E = Enablement - supports safe medical procedures by detecting infections

S = Surveillance - real-time tracking of infections, spread andtrends

👏 Second: A big, specific global collaboration for diagnostics launched - DxAMR - joined by organisations that have been traditionally more focused on antibiotics. Organised by Fleming Initiative, Global Antibiotic R&D Partnership (GARDP) an FIND

💡 Why is this important for startups and innovation?

These global organisations are really rallying together for diagnostics in AMR.

And innovation cannot stand alone, it doesn’t just need development, it needs adoption and recognition for its full value so we can truly transform healthcare."

https://www.linkedin.com/in/davidswilson/recent-activity/reactions/

Gmcc

FYI

Avacta website update today

https://avacta.com/careers/contracts-manager-paralegal/

https://avacta.com/wp-content/uploads/2025/07/Avacta-Thx-Contracts-Manager-job-spec-2025.pdf

gmcc

FYI

Craig FosterCraig Foster

• 3rd+3rd+

CEO Ondo InsurTech PlcCEO Ondo InsurTech Plc

16h • 16 hours ago • Visible to anyone on or off LinkedIn

Follow

What a fantastic day at Nationwide HQ in Columbus. Nationwide are a true pioneer when it comes to transitioning insurance to proactive predict and prevent. Happy to be alongside Bob Marshall from Whisker Labs in helping to make Nationwide's strategy come alive. Visionary leadership from Casey Kempton and the all the team Veronica Andersen, MBA, CPCU, AIC, LSSBB, Sarah Jacobs, Tiffany Grinstead it was great to hang out with you all for the day - exciting times ahead.

View Veronica Andersen, MBA, CPCU, AIC, LSSBB’s graphic link

Veronica Andersen, MBA, CPCU, AIC, LSSBBVeronica Andersen, MBA, CPCU, AIC, LSSBB

• 3rd+3rd+

Risk Solutions Director | Transforming Risk Through Predictive Solutions & Operational Excellence | Driving Predict & Prevent StrategiesRisk Solutions Director | Transforming Risk Through Predictive Solutions & Operational Excellence | Driving Predict & Prevent Strategies

23h • 23 hours ago • Visible to anyone on or off LinkedIn

Follow

What an exciting day focused on the future of smart home protection!

We spent the day immersed in purpose-driven collaboration—bringing together innovative minds and meaningful conversations to further Nationwide’s commitment to protecting what matters most.

🎙️ The highlight? Filming an upcoming episode of our Agency Forward podcast, featuring insightful perspectives from Sarah Jacobs, Bob Marshall, and Craig Foster, and moderated by the always thoughtful Tiffany Grinstead.

Smart home technology is transforming the way we protect homes, and Nationwide is proud to partner with agents to bring proactive, protective solutions to more families.

Huge thanks to our incredible marketing team for bringing the podcast to life with meaningful content and thoughtful execution.

hashtag#SmartHome hashtag#InsuranceInnovation hashtag#AgencyForward hashtag#ProtectWhatMatters hashtag#Nationwide hashtag#Collaboration hashtag#FutureFocused

Activate to view larger image,

No alternative text description for this image

https://www.linkedin.com/in/fosterc/recent-activity/all/

Gmcc

Good Morning - Courtesy - Ruairidh Edwards Principal Scientist at Avacta

Posts some interesting links : Avacta aslso use Tempus .

"

Tempus AITempus AI

104,200 followers104,200 followers

16h • 16 hours ago • Visible to anyone on or off LinkedIn

Follow

We’re excited to announce the expansion of our care pathway intelligence platform, Tempus Next, into breast cancer. The platform will support five different biomarker testing gaps specific to breast cancer with the goal of helping physicians deliver guideline-directed medical care to eligible patients.

Learn more: https://tempus.co/3GqkikA"

https://www.tempus.com/news/pr/tempus-expands-ai-enabled-care-pathway-intelligence-platform-into-breast-cancer/?utm_source=linkedin&utm_medium=organic_social&utm_campaign=next_breast&utm_term=june-2025&utm_content=learn_more

https://www.linkedin.com/in/ruairidh-edwards-4882658a/recent-activity/reactions/

Gmcc

Thanks

https://x.com/OndoPlc/status/1942463667229884438

gmcc

Good point : "At the moment I'm more interested to see how many shares Avacta will need to print to cover £3m cash. It seems Plan A is to get Richard Hughes to persuade his wealthy mates to cough-up" Only be beneficial if shares issued had restrictions on when they could be sold -like options with a higher exercise SP price preferably 2026 date ( sticky ) Otherwise no point just continie to issues shares to pay CLN payments .

gmcc

"Mr. Bryant, who is based in the UK, will assist HCRx in identifying potential royalty acquisition and credit opportunities across the United Kingdom and European Union."

gmcc

Yes indeed might be a possibilty Bella6532 ;

David Bryant

https://www.businesswire.com/news/home/20240102827965/en/HealthCare-Royalty-Announces-Closing-of-Additional-Debt-Focused-Fund-Team-Expansion-and-Promotions

https://www.hcrx.com/

gmcc

Many thanks for sharing SandyR :

Avacta just need to deliver temporary finance action " walk the talk " Demonstrate to investors they have a working funding plan to service the clinical pipeline -get through 2025 . Completion of the phase one AVA6000 clinical data package results & AVA 6103 IND filing is paramount .

Not bothered what finance option they take , just get it done & stick with the plan .

Should then be a clear path to achieving pre|CISION® true asset value . Should open up many viable funding options be spoilt for choice - Still well worth the wait for a handsome investment return + deliver patient benefit , IMO .

gmcc

AGM Agenda

https://x.com/Skd884/status/1940086917208633657/photo/1

25 mins allocated for Q & A

Trust those attending think worthwhile - wait & see for feedback .

gmcc

Work in progress :

"Zeus Capital was appointed a joint broker to the Company, along with Peel Hunt as Nomad and joint broker and Panmure Liberum as joint broker. The Company continues to develop traction with a range of investors as it assesses options to extend the Group's cash runway and to further build value in the pre|CISION® platform."

work in progtrss

FYI

https://www.linkedin.com/company/coveainsuranceplc/posts/

Covéa InsuranceCovéa Insurance

27,894 followers27,894 followers

5h • 5 hours ago • Visible to anyone on or off LinkedIn

Follow

🌡️ With the hottest weather on record this month and drought officially declared in Yorkshire and the North West, the environmental cost of water leaks has never been higher.

💧 Every hidden leak wastes precious water, and the energy used to treat it - adding pressure to already strained resources.

That’s why we’re proud to offer LeakBot free to all Covéa Private Clients.

🔹 Prevents small leaks from becoming big claims

🔹 Reduces water damage by up to 70%

🔹 Monitors homes 24/7

🔹 Sends instant alerts to smartphone

🔹 Uses patented Thermi-Q tech to detect hidden leaks early

LeakBot doesn’t just protect homes - it helps protect the planet. 🌍

Let’s work together to reduce water waste and environmental impact, one leak at a time.

hashtag#LeakBot hashtag#ClimateAction hashtag#SmartHome hashtag#InsuranceInnovation hashtag#PrivateClients

Rebecca Wright, Marc Moss, Steve Cowley, Niall Mitchell, Tom Johnstone, Dave Jowett.

Your document has finished loading

likecelebrate

8

4 reposts

Like

Comment

gmcc

Good Morning

Thanks Bella6532 - One would like to think Avacta will have a few choices on funding options .

Be nice to see some upwards movement . Better execution required hopefully now got the right people in place .

IP asset value very understated IMO just a matter of time .

Good luck everyone

gmcc

Good Morning

FYI : https://www.linkedin.com/feed/update/urn:li:activity:7345375470693019649/

Craig FosterCraig Foster

• 3rd+3rd+

CEO Ondo InsurTech PlcCEO Ondo InsurTech Plc

21h • 21 hours ago • Visible to anyone on or off LinkedIn

Follow

I had the pleasure of meeting Jim at Nationwide's head office in Columbus a few weeks ago at a technology strategy away day. And it's nice to see how LeakBot is playing such central part in Nationwide's tech direction. Really nice to get some feedback directly from the group CTO! See below.

hashtag#ONDO hashtag#LEAKBOT

View Jim Fowler’s graphic link

Jim FowlerJim Fowler

• 3rd+3rd+

Nationwide Chief Technology Officer | Leading Digital TransformationNationwide Chief Technology Officer | Leading Digital Transformation

2d • Edited • 2 days ago • Edited • Visible to anyone on or off LinkedIn

Follow

At Nationwide, we believe that to serve our members well, we need to walk in their shoes — and be our own toughest critics. That’s why I always look for opportunities to experience our products and services firsthand.

Recently, my LeakBot sensor — part of a partnership between Nationwide and LeakBot — alerted me to a minor leak.

From the mobile application to the follow-up calls from LeakBot experts, the entire experience was seamless. The device detected the issue early, their team helped me troubleshoot, and they were ready to coordinate with Nationwide to dispatch a licensed plumber if needed.

It was a great reminder of how technology and partnerships can come together to proactively protect our members.

Thank you, LeakBot for the assist — and thank you to the Nationwide team for continuously finding ways to deliver extraordinary care to our members.

…more

Activate to view larger image,"

gmcc

REF Affyxell - last video update 12 months ago might be of interest ; Been a few changes in personnel since .

Need to mute speaker & change subtitles to English but gives you a good idea from the slides of the project - affimer/stem cell potential .

https://www.youtube.com/watch?v=hP0FBp1rESY

gmcc

Note : Thierry Uh President at Daewoong Innovation Holdings -Director departure from "AffyXell Therapeutics, Co., Ltd. · Full-timeAffyXell Therapeutics, Co., Ltd. · Feb 2020 - Jun 2025 · 5 yrs 5 mos "

Maybe explains recent job adverts . Perhaps Daewoong not happy with progress anyway along with the ex president Seng-Ho Jeon departure few months ago . All change it seems to the AffyXell management team .

-------------

https://www.linkedin.com/feed/update/urn:li:activity:7343966776369508352/

"Yesterday marked my last day at Daewoong Pharmaceuticals.

As I close this meaningful chapter, I’m filled with gratitude.

Serving as the President of Daewoong Innovation Holdings, I had the privilege of exploring countless opportunities and meeting incredible individuals across industry and academia.

As a founding partner of Freemind Investment, I thoroughly enjoyed working with exceptional companies and, of course, my partners Ram and Chris - thank you for the journey we shared.

With AffyXell Therapeutics, every turn brought excitement and new challenges. I’m deeply grateful for the support and sincere help from my colleagues, our investors, and advisors - too many to name, but each of you made a difference." etc

--------

Christina Marie Coughlin & Simon Thomas Bennett listed as board members.

http://affyxell.com/company/people.php?PHPSESSID=a724cb293c18a07c6301da3f72a8de93

gmcc

The full report : https://avacta.com/investors/research-analyst/

gmcc